More about

Remission

News
February 07, 2023
2 min read
Save

Some patients with familial Mediterranean fever may achieve colchicine-free remission

Some patients with familial Mediterranean fever may achieve colchicine-free remission

A small minority of patients with familial Mediterranean fever may be able to achieve colchicine-free remission, according to data published in Pediatric Rheumatology.

News
January 20, 2023
3 min read
Save

Curcumin-QingDai induces remission in active UC, ‘paves the way’ for integration in care

Curcumin-QingDai induces remission in active UC, ‘paves the way’ for integration in care

DENVER — The combination of herbal extracts curcumin and QingDai induced clinical response and remission in patients with active ulcerative colitis, according to data presented at the Crohn’s and Colitis Congress.

News
November 23, 2022
2 min read
Save

VEGA: Guselkumab plus golimumab achieved higher clinical remission rates in UC

VEGA: Guselkumab plus golimumab achieved higher clinical remission rates in UC

CHARLOTTE, N.C. — Guselkumab in combination with golimumab induced greater rates of clinical remission compared with monotherapy among patients with moderate to severely active ulcerative colitis.

News
November 11, 2022
2 min read
Save

Off-the-shelf CAR-T produces complete remission in patient with advanced kidney cancer

Off-the-shelf CAR-T produces complete remission in patient with advanced kidney cancer

Treatment with CTX130, a novel chimeric antigen receptor T-cell therapy, led to disease control in more than three quarters of patients with advanced clear cell renal cell carcinoma, results from a phase 1 trial showed.

News
October 26, 2022
5 min watch
Save

VIDEO: ‘No difference’ between ustekinumab, tofacitinib for steroid-free remission in UC

VIDEO: ‘No difference’ between ustekinumab, tofacitinib for steroid-free remission in UC

CHARLOTTE, N.C. — In a Healio video exclusive, Rahul Dalal, MD, MPH, reported ustekinumab and tofacitinib yielded similar safety and efficacy in the treatment of a small subset of adult patients with ulcerative colitis.

News
October 21, 2022
3 min watch
Save

VIDEO: Stelara safe, effective for the long-term treatment of moderate to severe UC

VIDEO: Stelara safe, effective for the long-term treatment of moderate to severe UC

VIENNA — In a Healio video exclusive, Waqqas Afif, MD, reports results from the phase 3 UNIFI study, in which Stelara safely demonstrated sustained symptomatic and corticosteroid-free remission in adults with ulcerative colitis.

News
October 19, 2022
1 min read
Save

Patients with IgA vasculitis nephritis achieved remission using immunosuppression therapy

Patients with IgA vasculitis nephritis achieved remission using immunosuppression therapy

Pediatric patients with IgA vasculitis nephritis and nephrotic-range proteinuria achieved remission after 12 months of mycophenolate mofetil-based immunosuppression treatment, according to data published in Kidney Medicine.

News
October 14, 2022
2 min read
Save

Use of telehealth platform linked to higher remission rate of suicidal ideation

Use of telehealth platform linked to higher remission rate of suicidal ideation

Those who received psychiatric care through a telehealth platform saw a greater level of remission in suicidal ideation after 12 weeks compared with those who did not receive similar care, researchers reported in JMIR Formative Research.

News
October 12, 2022
5 min watch
Save

VIDEO: Mirikizumab induces ‘rapid control’ of bowel urgency, symptomatic remission in UC

VIDEO: Mirikizumab induces ‘rapid control’ of bowel urgency, symptomatic remission in UC

VIENNA — In a Healio video exclusive, Maria T. Abreu, MD, reported mirikizumab induced “rapid control” of bowel movement urgency and fatigue among patients with mild to moderate ulcerative colitis.

News
October 04, 2022
2 min read
Save

Infliximab retreatment results in remission in 35% of patients with Crohn’s disease

Infliximab retreatment results in remission in 35% of patients with Crohn’s disease

After previously discontinuing infliximab, 35% of patients with Crohn’s disease achieved remission at 26 weeks with drug retreatment, according to a study published in The American Journal of Gastroenterology.

View more